Study on Infraspinatus-teres minor (ITM) interfascial block for analgesia during shoulder arthroscopic surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300078034

Enrollment

Unknown

Registered

2023-11-27

Start date

2023-12-01

Completion date

Unknown

Last updated

2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff injury

Interventions

ISB Group:interscalene block (ISB)

ITM Group:Infraspinatus-teres minor (ITM) interfascial block

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 80 years scheduled to undergo shoulder arthroscopic surgery

Exclusion criteria

Exclusion criteria: ASA grade = IV, history of obstructive or restrictive lung disease, BMI >35 kg/m², coagulation disorder, liver or kidney failure, sepsis, pregnancy, local anesthetic allergy, long-term use of opioids, history of neck surgery, Presence of neurological deficits, peripheral neuropathy, chronic pain syndromes, and cognitive impairment before surgery

Design outcomes

Primary

Measure	Time frame
pain score;complication;	—

Secondary

Measure	Time frame
Intraoperative opioid dosage;Incidence of diaphragmatic paralysis;Cumulative opioid consumption 48 hours postoperatively;Time to first analgesia required by PCA;Pulmonary function test;patient satisfaction ratings;	—

Countries

China

Contacts

Public ContactQIAN ZHUO

Wenzhou People's Hospital

amos.zq@gmail.com+86 135 8765 7628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026